Lilly’s New Obesity Awareness Campaign Seeks to Shift Obesity Discourse from Blame to Science and Empathy

▴ Lilly's obesity awareness campaign featuring Varalaxmi Sarathkumar and Nicholai Sachdev
Campaign blends lived experiences with science led perspectives to challenge obesity stigma and emphasise the importance of guidance from doctors.

New Delhi, 26th February 2026: Eli Lilly and Company (India) today announced the next phase of its integrated obesity awareness initiative with a new campaign aimed at reshaping how obesity is perceived and discussed in India. The campaign, led by prominent Indian personalities, blends real-life experiences with science-led perspectives to encourage a shift in conversation from judgment and appearance towards science and empathy, reinforcing the importance of consulting a doctor as part of a comprehensive obesity care pathway. As part of the campaign, three films have been developed: the first featuring Boman Irani and Kayoze Irani; the second with Ratna Pathak Shah and Supriya Pathak; and the third featuring Varalaxmi Sarathkumar.

Obesity in India is often reduced to a question of willpower and lifestyle alone. This campaign challenges that perception by underscoring a science-based reality; as recognized by the World Health Organization (WHO), obesity is a chronic, complex disease influenced by biological, genetic, environmental, and metabolic factors. Drawing on relatable family and social contexts, the campaign reflects the experiences of individuals who frequently face judgment and self-blame, reframing these moments with empathy and scientific understanding. Within the campaign films these prominent personalities highlight the important supportive role friends and family can have in showing empathy, encouragement, and understanding, that can make visiting a doctor feel empowering rather than shameful. At the same time, the campaign affirms obesity as a medical condition, placing doctors at the centre of diagnosis and evidence-based care to encourage informed decision making and foster a more compassionate public narrative.

“Obesity has long been misunderstood in India, frequently framed as a matter of personal choice rather than acknowledged as a complex medical condition,” said Gaurav Mehta, Senior Director, Marketing and Strategic Capabilities, Eli Lilly and Company (India). “Through this next phase of our campaign, we aim to reframe the conversation by combining scientific insight with relatable, real-life narratives that reflect the lived experience of people living with obesity. Our focus is to move the dialogue from blame to understanding, reduce stigma, and empower individuals to seek appropriate, evidence-based care in consultation with qualified doctors who play a central role across the treatment journey.” 

Links to campaign films:

Obesity affects nearly 100 million individuals in India. With an adult obesity prevalence of approximately 6.5 percent in 2023, it is time to shift focus from blame and establish a new paradigm for comprehensive care along with lifestyle modification that people living with obesity deserve.1

To learn more about obesity, visit Obesity Disease & Weight Loss Health Education | Lilly India

The campaign is intended for disease awareness and education purposes only and does not promote any specific product, treatment, or therapy. Individuals are encouraged to consult qualified healthcare professionals for medical advice.

Tags : #

About the Author


Team Medicircle

Related Stories

Loading Please wait...

-Advertisements-



Trending Now

Healthcare Trends in 2026: What India's Doctors, Hospitals, and Patients Need to KnowJuly 18, 2026
Monsoon Health Problems in India: Understanding the Risks, Symptoms, and PreventionJuly 18, 2026
Fortis Escorts Faridabad Launches Faridabad’s First Comprehensive Lung Failure Clinic for Advanced Respiratory and Transplant CareJuly 17, 2026
What Seemed Like Persistent Gas Turned Out To Be A 30-cm Rare Cancer Occupying Most Of Her AbdomenJuly 17, 2026
Kidney Stone Prevention Initiative Unites More Than 8,200 Doctors Across India, Earns Asia Book of Records RecognitionJuly 17, 2026
Moscow radiologists introduce AI tool for hip dysplasia diagnosisJuly 17, 2026
Sharrp Ventures leads 100 CR investment in Naturis Cosmetics’ first institutional funding roundJuly 17, 2026
Eugenix Challenges Hair Loss Stigma With Nationwide 'I Chose Transformation' Campaign Featuring Boney KapoorJuly 17, 2026
How Artificial Intelligence is Reshaping Preventive Healthcare Through Earlier Detection and Smarter Clinical InsightsJuly 17, 2026
Five Common Myths About Children's Urinary Problems That Parents Should Stop BelievingJuly 17, 2026
Robotics in Surgery: How Robot-Assisted Procedures Are Transforming Healthcare in IndiaJuly 17, 2026
Wearable Health Devices: How Smart Technology Is Changing Healthcare in IndiaJuly 17, 2026
Sankara Eye Hospitals Successfully Hosts 20th Annual VISION 2020 India Conference, Celebrating 50 Years of the Sankara MovementJuly 16, 2026
Manipal Hospital Bhubaneswar Successfully Treats Rare Brain Injury Caused by Post-Traumatic Workplace AccidentJuly 16, 2026
Immuneel Therapeutics and Tata Memorial Centre Sign Strategic MoU to Advance Cell and Gene Therapy Research in India July 16, 2026
Breast Cancer Early Warning Signs: What Every Woman in India Needs to KnowJuly 16, 2026
HbA1c Test Explained: What It Measures, Normal Range, and Why It Matters for IndiansJuly 16, 2026
Not Just Weight Loss: How Bariatric Surgery Improves Diabetes, PCOS, and Thyroid-Related Health ChallengesJuly 15, 2026
Leiutis Pharmaceuticals announces CDSCO approval for Global-First Synthetic CBD Therapy for Mild to Moderate Anxiety DisordersJuly 15, 2026
Dr Agarwals Institute of Optometry and SASTRA University Jointly Launch Optometry ProgrammeJuly 15, 2026